Acquisition of meiotic DNA repair regulators maintain genome stability in glioblastoma

le Rivera, M, Wu, Q, Hamerlik, P, Hjelmeland, A B, Bao, S, Rich, J N
Foilsithe in Cell Death Dis (2015)

P08.18 Replication stress as a driver of genomic instability in malignant gliomas

le Rasmussen, R., Gajjar, M., Tuckova, L., Jensen, K., Maya-Mendoza, A., Bartek, J., Hamerlik, P.
Foilsithe in Neuro Oncol (2017)

P08.06 Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

le Urup, T., Staunstrup, L., Michaelsen, S., Vitting-Seerup, K., Bennedbæk, M., Toft, A., Broholm, H., Hamerlik, P., Poulsen, H., Lassen, U.
Foilsithe in Neuro Oncol (2016)

P01.12 VEGF-C contributes to autocrine VEGF Receptor 2 signaling and cellular maintenance in Glioblastoma

le Michaelsen, S. R., Nedergaard, M. K., Broholm, H., Bartkova, J., Staberg, M., Aghi, M., Lucacova, S., Perryman, L., Poulsen, H. S., Hamerlik, P.
Foilsithe in Neuro Oncol (2016)

Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact

le Fornara, O, Bartek Jr, J, Rahbar, A, Odeberg, J, Khan, Z, Peredo, I, Hamerlik, P, Bartek, J, Stragliotto, G, Landázuri, N, Söderberg-Nauclér, C
Foilsithe in Cell Death Differ (2016)

Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells

le Venere, M, Hamerlik, P, Wu, Q, Rasmussen, R D, Song, L A, Vasanji, A, Tenley, N, Flavahan, W A, Hjelmeland, A B, Bartek, J, Rich, J N
Foilsithe 2014